Victory Capital Management
JANX icon

Victory Capital Management’s Janux Therapeutics JANX Stock Holding History

Victory Capital Management’s Portfolio JANX Stock Details JANX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$82.7K Hold
5,953
– – ﹤0.01% 2281
2025
Q4 		$82.2K Buy
5,953
+1,090
+22% +$25.6K ﹤0.01% 2288
2025
Q3 		$119K Sell
4,863
-177,203
-97% -$4.32M ﹤0.01% 2279
2025
Q2 		$4.21M Sell
182,066
-83,585
-31% -$2.2M ﹤0.01% 1367
2025
Q1 		$7.17M Buy
265,651
+23,242
+10% +$876K 0.01% 1171
2024
Q4 		$13M Buy
242,409
+212,664
+715% +$11.2M 0.01% 992
2024
Q3 		$1.35M Buy
29,745
+17,525
+143% +$762K ﹤0.01% 1646
2024
Q2 		$512K Buy
+12,220
New +$574K ﹤0.01% 1971

Other funds holding JANX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return